ZYMERGEN INC (ZY) Stock News
NASDAQ:ZY - Nasdaq - US98985X1000 - Common Stock - Currency: USD
ZY Latest News, Press Relases and Analysis
Ginkgo Bioworks Completes Acquisition of Zymergen
/PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, and Zymergen (Nasdaq: ZY) announced that Ginkgo has...
Mentions: DNA
Ginkgo Bioworks Expands Horizontal Synthetic Biology Platform With This Stock Deal
Mentions: DNA
Nu Holdings, Ally Financial And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) shares rose 17.5% to $4.10 in pre-market trading after the company said Q2 sales results were up year over year and raised FY22 sales guidance above estimates.
Zymergen (ZY) Stock Soars 20% on Acquisition News
Zymergen finally received some much-needed good news when Ginkgo Bioworks agreed to buy out the firm, sending ZY stock soaring.
Mentions: DNA
Ginkgo to Acquire Zymergen
Acquisition is expected to accelerate the development of Ginkgo's innovative horizontal synthetic biology platform Expect integration of Zymergen's...
Mentions: DNA
SHAREHOLDER ALERT: Weiss Law Investigates Infrastructure and Zymergen Inc.
/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Zymergen Inc....
Mentions: DNA
Cathie Wood Loaded Up on Zymergen (ZY) Stock Before Ginkgo Buyout
Zymergen shares are rallying after an all-stock buyout from Ginkgo Bioworks. Cathie Wood's Ark owns both DNA shares and ZY stock.
Why Is Ginkgo Bioworks (DNA) Stock in the Spotlight Today?
DNA stock is down even while Ginkgo Bioworks prepares to purchase a biotech business and a large research and development site.
Mentions: DNA
Shareholder Alert: Ademi LLP investigates whether Zymergen Inc. has obtained a Fair Price in its transaction with Ginkgo
/PRNewswire/ -- Ademi LLP is investigating Zymergen (NASDAQ: ZY) for possible breaches of fiduciary duty and other violations of law in its transaction with...
ZY Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Zymergen Inc. Is Fair to Shareholders
Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform
Octant doubles its initial investment in Zymergen’s Automation Technology to significantly increase the scale and throughput of its drug discovery...
Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing Applications
EMERYVILLE, Calif., June 28, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced an R&D supply agreement to provide...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, investors! Busy traders are already at work this morning as we go over the biggest pre-market stock movers for Wednesday.
Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery Platform
EMERYVILLE, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today announced it has entered into an agreement with...